Showing results (671-680 of 4,871) with videos related to
Sort By:
Pageof 488
Urologic Oncology|September 23, 2008
Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of viewMatthias May, Sabine Brookman-Amissah, Jan Roigas, et al.Urologic Oncology|September 27, 2008
Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Toshifumi Kurahashi, Atsushi Takenaka, et al.Urologic Oncology|September 27, 2008
"Cancer stem cells"-lessons from Hercules to fight the HydraFelix Roman Moltzahn, Jens-Peter Volkmer, Daniel Rottke, et al.Urologic Oncology|September 16, 2008
Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: a Phase II studyMohammad Reza SafarinejadUrologic Oncology|September 19, 2008
Radiosensitivity of prostate cancer cells is enhanced by EGFR inhibitor C225Feng Liu, Jun-Jie Wang, Zhen-Yu You, et al.Urologic Oncology|September 19, 2008
A microRNA expression ratio defining the invasive phenotype in bladder tumorsLori A Neely, Kimberly M Rieger-Christ, Brasil Silva Neto, et al.Urologic Oncology|July 3, 2008
Current status of cytotoxic chemotherapy in patients with metastatic prostate cancerRobert DreicerUrologic Oncology|September 22, 2009
Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinomaJa Hyeon Ku, Kyung Chul Moon, Cheol Kwak, et al.Urologic Oncology|November 11, 2008
Probabilities and preferences: what economics can teach doctors and patients making difficult treatment decisionsBenjamin D Sommers, Richard ZeckhauserUrologic Oncology|December 17, 2008
The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approachKelly Swords, Eric M Wallen, Raj S PruthiPageof 488